Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.08
AMSG's Cash to Debt is ranked higher than
57% of the 242 Companies
in the Global Medical Care industry.

( Industry Median: 0.22 vs. AMSG: 0.08 )
AMSG' s 10-Year Cash to Debt Range
Min: 0.07   Max: 1.51
Current: 0.08

0.07
1.51
Equity to Asset 0.36
AMSG's Equity to Asset is ranked higher than
62% of the 234 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. AMSG: 0.36 )
AMSG' s 10-Year Equity to Asset Range
Min: 0.34   Max: 0.8
Current: 0.36

0.34
0.8
Interest Coverage 16.55
AMSG's Interest Coverage is ranked higher than
85% of the 155 Companies
in the Global Medical Care industry.

( Industry Median: 5.49 vs. AMSG: 16.55 )
AMSG' s 10-Year Interest Coverage Range
Min: 9.19   Max: 65.45
Current: 16.55

9.19
65.45
F-Score: 6
Z-Score: 2.03
M-Score: -2.97
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 9/10

vs
industry
vs
history
Operating margin (%) 30.41
AMSG's Operating margin (%) is ranked higher than
98% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 9.44 vs. AMSG: 30.41 )
AMSG' s 10-Year Operating margin (%) Range
Min: 25.61   Max: 63.3
Current: 30.41

25.61
63.3
Net-margin (%) 6.78
AMSG's Net-margin (%) is ranked higher than
81% of the 236 Companies
in the Global Medical Care industry.

( Industry Median: 4.97 vs. AMSG: 6.78 )
AMSG' s 10-Year Net-margin (%) Range
Min: 0.17   Max: 12
Current: 6.78

0.17
12
ROE (%) 9.07
AMSG's ROE (%) is ranked higher than
75% of the 229 Companies
in the Global Medical Care industry.

( Industry Median: 8.44 vs. AMSG: 9.07 )
AMSG' s 10-Year ROE (%) Range
Min: 0.28   Max: 15.62
Current: 9.07

0.28
15.62
ROA (%) 3.06
AMSG's ROA (%) is ranked higher than
71% of the 237 Companies
in the Global Medical Care industry.

( Industry Median: 3.63 vs. AMSG: 3.06 )
AMSG' s 10-Year ROA (%) Range
Min: 0.13   Max: 9.34
Current: 3.06

0.13
9.34
ROC (Joel Greenblatt) (%) 114.41
AMSG's ROC (Joel Greenblatt) (%) is ranked higher than
95% of the 235 Companies
in the Global Medical Care industry.

( Industry Median: 16.84 vs. AMSG: 114.41 )
AMSG' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 55.68   Max: 194.75
Current: 114.41

55.68
194.75
Revenue Growth (%) 11.00
AMSG's Revenue Growth (%) is ranked higher than
85% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 7.00 vs. AMSG: 11.00 )
AMSG' s 10-Year Revenue Growth (%) Range
Min: 9.9   Max: 19.4
Current: 11

9.9
19.4
EBITDA Growth (%) 7.50
AMSG's EBITDA Growth (%) is ranked higher than
78% of the 171 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. AMSG: 7.50 )
AMSG' s 10-Year EBITDA Growth (%) Range
Min: -9   Max: 40.6
Current: 7.5

-9
40.6
EPS Growth (%) 5.50
AMSG's EPS Growth (%) is ranked higher than
69% of the 153 Companies
in the Global Medical Care industry.

( Industry Median: 10.90 vs. AMSG: 5.50 )
AMSG' s 10-Year EPS Growth (%) Range
Min: 1.3   Max: 135.1
Current: 5.5

1.3
135.1
» AMSG's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q2 2013

AMSG Guru Trades in Q2 2013

Jim Simons 152,769 sh (+1.06%)
Paul Tudor Jones Sold Out
Steven Cohen Sold Out
Jeremy Grantham 10,500 sh (-3.67%)
» More
Q3 2013

AMSG Guru Trades in Q3 2013

Paul Tudor Jones 7,600 sh (New)
Jim Simons 133,100 sh (-12.87%)
Jeremy Grantham 8,300 sh (-20.95%)
» More
Q4 2013

AMSG Guru Trades in Q4 2013

Paul Tudor Jones 11,400 sh (+50%)
Jim Simons 150,500 sh (+13.07%)
Jeremy Grantham 8,600 sh (+3.61%)
» More
Q1 2014

AMSG Guru Trades in Q1 2014

Joel Greenblatt 123,375 sh (New)
Jim Simons 237,969 sh (+58.12%)
Jeremy Grantham Sold Out
Paul Tudor Jones Sold Out
» More
» Details

Insider Trades

Latest Guru Trades with AMSG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2014-03-31 New Buy0.09%$40.4 - $47.08 $ 47.368%123375
Joel Greenblatt 2013-03-31 Sold Out 0.02%$29.41 - $33.64 $ 47.3651%0
Joel Greenblatt 2012-12-31 New Buy0.02%$25.98 - $30.47 $ 47.3668%11738
Joel Greenblatt 2011-12-31 Sold Out 0.06%$21.7 - $26.71 $ 47.3690%0
Joel Greenblatt 2011-09-30 New Buy0.06%$19.92 - $27.59 $ 47.36103%15843
David Dreman 2011-06-30 Sold Out $24.56 - $26.98 $ 47.3683%0
Premium More recent guru trades are included for Premium Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 21.00
AMSG's P/E(ttm) is ranked higher than
86% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 41.50 vs. AMSG: 21.00 )
AMSG' s 10-Year P/E(ttm) Range
Min: 9.07   Max: 28.78
Current: 21

9.07
28.78
P/B 1.97
AMSG's P/B is ranked higher than
82% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 2.89 vs. AMSG: 1.97 )
AMSG' s 10-Year P/B Range
Min: 0.93   Max: 3.54
Current: 1.97

0.93
3.54
P/S 1.40
AMSG's P/S is ranked higher than
71% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 1.63 vs. AMSG: 1.40 )
AMSG' s 10-Year P/S Range
Min: 0.7   Max: 3.01
Current: 1.4

0.7
3.01
PFCF 5.07
AMSG's PFCF is ranked higher than
98% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 33.00 vs. AMSG: 5.07 )
AMSG' s 10-Year PFCF Range
Min: 1.92   Max: 28.87
Current: 5.07

1.92
28.87
EV-to-EBIT 7.25
AMSG's EV-to-EBIT is ranked higher than
98% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 26.76 vs. AMSG: 7.25 )
AMSG' s 10-Year EV-to-EBIT Range
Min: 3   Max: 9
Current: 7.25

3
9
PEG 3.07
AMSG's PEG is ranked higher than
84% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. AMSG: 3.07 )
AMSG' s 10-Year PEG Range
Min: 0.3   Max: 10.76
Current: 3.07

0.3
10.76
Shiller P/E 24.99
AMSG's Shiller P/E is ranked higher than
90% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. AMSG: 24.99 )
AMSG' s 10-Year Shiller P/E Range
Min: 9.92   Max: 55.1
Current: 24.99

9.92
55.1
Current Ratio 2.49
AMSG's Current Ratio is ranked higher than
92% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.39 vs. AMSG: 2.49 )
AMSG' s 10-Year Current Ratio Range
Min: 1.91   Max: 4.94
Current: 2.49

1.91
4.94
Quick Ratio 2.27
AMSG's Quick Ratio is ranked higher than
92% of the 238 Companies
in the Global Medical Care industry.

( Industry Median: 1.24 vs. AMSG: 2.27 )
AMSG' s 10-Year Quick Ratio Range
Min: 1.8   Max: 4.62
Current: 2.27

1.8
4.62

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 0.38
AMSG's Price/DCF (Projected) is ranked higher than
99% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 3.93 vs. AMSG: 0.38 )
AMSG' s 10-Year Price/DCF (Projected) Range
Min: 0.24   Max: 2.51
Current: 0.38

0.24
2.51
Price/Median PS Value 1.05
AMSG's Price/Median PS Value is ranked higher than
79% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 1.26 vs. AMSG: 1.05 )
AMSG' s 10-Year Price/Median PS Value Range
Min: 0.49   Max: 2.1
Current: 1.05

0.49
2.1
Price/Peter Lynch Fair Value 2.30
AMSG's Price/Peter Lynch Fair Value is ranked higher than
88% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 9999.00 vs. AMSG: 2.30 )
AMSG' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.4   Max: 4.76
Current: 2.3

0.4
4.76
Earnings Yield (Greenblatt) 13.80
AMSG's Earnings Yield (Greenblatt) is ranked higher than
96% of the 226 Companies
in the Global Medical Care industry.

( Industry Median: 5.20 vs. AMSG: 13.80 )
AMSG' s 10-Year Earnings Yield (Greenblatt) Range
Min: 11.2   Max: 33
Current: 13.8

11.2
33
Forward Rate of Return (Yacktman) 22.47
AMSG's Forward Rate of Return (Yacktman) is ranked higher than
89% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 10.49 vs. AMSG: 22.47 )
AMSG' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -0.1   Max: 56.5
Current: 22.47

-0.1
56.5

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:AJH.Germany
AmSurg Corp was formed in 1992. The Company owns and operates short stay ambulatory surgery centers. It owns approximately 51% interest in the facilities that it operates. Its surgical facilities provide non-elective, high volume, lower-risk surgical procedures across multiple specialties, including among others gastroenterology, and orthopedics. The Company acquires, develops and operates ASCs through the formation of partnerships with physicians to serve the communities in its markets.
» More Articles for AMSG

Headlines

Articles On GuruFocus.com
Weekly CFO Sells Highlight: V, SCLN, VR, AMSG Jun 25 2012 
predictable Sep 28 2011 
AmSurg Corp: Free Cash Flow not what it seems (AMSG) Aug 04 2011 
Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 30,000 Shares Mar 17 2011 
Amsurg Corp. (AMSG) Executive VP & CFO Claire M Gulmi sells 27,500 Shares Nov 12 2010 
Amsurg Corp. Reports Operating Results (10-Q) Nov 05 2010 
View on AMSG Apr 30 2010 
Amsurg Corp. Reports Operating Results (10-Q) May 09 2009 


More From Other Websites
AMSURG CORP Files SEC form 10-Q, Quarterly Report Aug 01 2014
Is Obamacare a Long Term Tailwind for Creating Value for Senior Housing REITs? A Wall Street... Aug 01 2014
How AmSurg (AMSG) Stock Stands Out in a Strong Industry Aug 01 2014
AmSurg Reports Second-Quarter 2014 Results Jul 31 2014
Amsurg Corp Earnings Call scheduled for 5:00 pm ET today Jul 31 2014
4:08 pm AmSurg reports EPS in-line, revs in-line; guides Q3 EPS below consensus; raised 2014... Jul 31 2014
AMSURG CORP Files SEC form 8-K, Results of Operations and Financial Condition Jul 31 2014
AmSurg Reports Second-Quarter 2014 Results Jul 31 2014
Q2 2014 AmSurg Corporation Earnings Release - After Market Close Jul 31 2014
Why Earnings Season Could Be Great for AmSurg (AMSG) Jul 30 2014
The Zacks Analyst Blog Highlights: Biogen Idec, Roche Holding, AbbVie, AmSurg and Acadia Healthcare Jul 24 2014
AMSURG CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Jul 22 2014
DaVita's Domestic Acquisitions Look Good, Debt Lingers Jul 18 2014
AmSurg Corp. Completes Acquisition of Sheridan Healthcare Jul 16 2014
AMSURG CORP Files SEC form 8-K, Financial Statements and Exhibits Jul 16 2014
AmSurg Corp. Completes Acquisition of Sheridan Healthcare Jul 16 2014
CVS Caremark to Expand with Navarro Discount Pharmacy Buyout Jul 15 2014
AMSURG CORP Financials Jul 10 2014
AmSurg Up to Strong Buy on Sheridan Healthcare Buyout Plan Jul 08 2014
AmSurg Corp. Sets Earnings Release and Conference Call Dates for Second Quarter 2014 Results Jul 03 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK
Email Hide